Fiasp Flextouch Pen 100 Units / mL

Fiasp FlexTouch Pen 100

Fiasp Flex Touch
Insulin Aspart
Select product strength & quantity:

Prescription Required.

Product of Canada.

Express Ships from Canada.

Prescription Required.
Product of Canada.
Express Ships from Canada.

Fiasp Flextouch Insulin Pen


The Fiasp FlexTouch Pen is a fast-acting type of insulin that is used by adults and children with type 1 or type 2 diabetes. It effectively manages blood glucose (sugar) levels and avoid developing any serious complications.

The active molecule in Fiasp® is identical to NovoLog®.

The Fiasp® formulation contains Vitamin B3 (niacinamide) and L-arginine to stabilize the formulation.

It is taken to replace insulin that is not sufficiently produced by the body and helps properly deliver glucose into cells.

Typically it is prescribed by doctors along with long-acting insulin types and other diabetes medications.

Fiasp insulin should be used as part of a treatment program that should also incorporate a proper diet, regular exercise and weight loss as instructed by your doctor.

By taking Fiasp insulin as part of your diabetes treatment you will be able to live a healthy and normal life.

Fiasp FlexTouch has been shown to be safe during breastfeeding. Studies have shown that the medication does not pass into breast milk in significant amounts and is not harmful to babies.

Fiasp FlexTouch Pen Usage

A doctor or nurse should instruct you on how to properly administer this medication which is taken by injecting under the skin (subcutaneously).

It is usually taken either 15 minutes before meal time or 20 minutes after starting your meal. It’s important to monitor your blood sugar levels regularly, keep track of your results in order to share this information with your physician in order for them to prescribe the ideal dosage.

After 10-20 minutes of injection it will begin to lower blood sugar levels and can last up to 3-5 hours. Ask your doctor about when and where to inject your insulin medication in order for it to provide optimal effectiveness.

Rotate injection sites in order to avoid developing hard lumps (lypodystrophy) to a certain area of the body.

For faster absorption, inject below the skin of the abdomen.

Side Effects

Hypoglycemia (low blood sugar) is the most common side effect associated with using Fiasp insulin. To prevent this, it’s important to always administer the correct dosage as advised by your doctor, take medication with meals and monitor blood sugar levels regularly.

Other common side effects include:

  • Allergic reactions at injection sites such as itching, swelling, redness, skin thickening or hard lumps (lypodystrophy)
  • Weight gain
  • Dizziness
  • Trouble breathing
  • Muscle cramps
  • Weakness

Side effects typically go away as your body adjusts and do not require medical attention. If you are concerned about any side effects then you should consult with your doctor.

If you are experiencing any symptoms of hypoglycemia such as tremors, weakness, anxiety, cool pale skin, cold sweats, you should carry a sugary food such as candy or fruit juice.

If you notice any other side effects that are not listed above, contact your doctor or pharmacist.


Do not use this medication if you have hypoglycemia.

Notify your doctor immediately if you have any liver, kidney or heart problems prior to beginning your treatment.

Pregnant or breastfeeding women should discuss taking this medication with their physician before starting treatment as the dosage may need to be adjusted.

You should not stop taking this medication unless instructed by your doctor.

Excessive alcohol consumption can lead to hypoglycemia.

If you miss a dose of Fiasp FlexTouch, you should check your blood sugar levels to ensure they do not become too high (hyperglycemia).

Do not share your Fiasp FlexTouch Pen, needles or syringes with other patients as it can lead to the transmission of blood-borne pathogens.

Any changes to insulin type, manufacturer, strength, method of administration or dosage may cause a predisposition to hypoglycemia or hyperglycemia. All changes to your insulin regimen should be under medical supervision.

Keep in mind, your doctor has prescribed this insulin because it is likely the ideal medication for your condition and benefits far outweigh the risks. Most people do not experience any side effects.

Fiasp® FlexTouch® Storage

Unopened containers should be stored in the refrigerator. Do not freeze or use if insulin has previously been frozen.

Not in use (unopened): If unopened, Fiasp® FlexTouch® should be stored in a refrigerator (36°F to 46°F [2°C to 8°C]) until expiration date. If unopened but improperly stored outside of refrigerated conditions, begin in-use storage for a maximum of 4 weeks.1

In use (opened): After first use, Fiasp® FlexTouch® can be stored at room temperature (below 86°F [30°C]) or in the refrigerator (36°F to 46°F [2°C to 8°C]) without the needle attached for a maximum of 4 weeks (28 days).1

Keep insulin away from light or heat. Throw away any part if not used after 28 days after opening.

Keep all medication in a safe place and away from children or pets.

When discarding medication, do not throw down waste water.

Speak to your pharmacist about the best way to throw out your drugs.

Do not use this medication if it is no longer clear and colorless or contains particles.

Additional Information

Manufacturer: Novo Nordisk Ltd
Salt Composition: Insulin Aspart (100IU/ml)
Other Brand Names: Brand Name: Fiasp FlexTouch, NovoLog FlexPen, NovoLog PenFill

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at

Other products by Fiasp®

Fiasp Cartridges

 100u/mL – 5 cartridges

Fiasp Vial 10 ml 100 Units / mL

100u/mL – 1 vials